Follow
Stefano Tomassi
Stefano Tomassi
Verified email at unina.it
Title
Cited by
Cited by
Year
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities
D Rotili, S Tomassi, M Conte, R Benedetti, M Tortorici, G Ciossani, ...
Journal of medicinal chemistry 57 (1), 42-55, 2014
1332014
Targeting drug resistance in EGFR with covalent inhibitors: a structure-based design approach
J Engel, A Richters, M Getlik, S Tomassi, M Keul, M Termathe, J Lategahn, ...
Journal of medicinal chemistry 58 (17), 6844-6863, 2015
1042015
Phenotypic identification of a novel autophagy inhibitor chemotype targeting lipid kinase VPS34
L Robke, L Laraia, MA Carnero Corrales, G Konstantinidis, M Muroi, ...
Angewandte Chemie International Edition 56 (28), 8153-8157, 2017
602017
Indazole-based covalent inhibitors to target drug-resistant epidermal growth factor receptor
S Tomassi, J Lategahn, J Engel, M Keul, HL Tumbrink, J Ketzer, ...
Journal of medicinal chemistry 60 (6), 2361-2372, 2017
532017
Boosting Fmoc solid-phase peptide synthesis by ultrasonication
F Merlino, S Tomassi, AM Yousif, A Messere, L Marinelli, P Grieco, ...
Organic letters 21 (16), 6378-6382, 2019
462019
Novel Reversible Monoamine Oxidase A Inhibitors: Highly Potent and Selective 3-(1H-Pyrrol-3-yl)-2-oxazolidinones
S Valente, S Tomassi, G Tempera, S Saccoccio, E Agostinelli, A Mai
Journal of medicinal chemistry 54 (23), 8228-8232, 2011
412011
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells
S Valente, I Lepore, C Dell'Aversana, M Tardugno, S Castellano, ...
Biochimie 94 (11), 2308-2313, 2012
382012
From a Helix to a Small Cycle: Metadynamics‐Inspired αvβ6 Integrin Selective Ligands
FS Di Leva, S Tomassi, S Di Maro, F Reichart, J Notni, A Dangi, ...
Angewandte Chemie International Edition 57 (44), 14645-14649, 2018
342018
Quinoline‐based p300 histone acetyltransferase inhibitors with pro‐apoptotic activity in human leukemia U937 cells
A Lenoci, S Tomassi, M Conte, R Benedetti, V Rodriguez, S Carradori, ...
ChemMedChem 9 (3), 542-548, 2014
322014
Exploring the N-terminal region of CXC motif chemokine 12 (CXCL12): identification of plasma-stable cyclic peptides as novel, potent CXC chemokine receptor type 4 (CXCR4 …
S Di Maro, AM Trotta, D Brancaccio, FS Di Leva, V La Pietra, C Ierano, ...
Journal of Medicinal Chemistry 59 (18), 8369-8380, 2016
312016
Polycomb repressive complex 2 modulation through the development of EZH2–EED interaction inhibitors and EED binders
S Tomassi, A Romanelli, C Zwergel, S Valente, A Mai
Journal of Medicinal Chemistry 64 (16), 11774-11797, 2021
272021
Ligand-based NMR study of CXC chemokine receptor type 4 (CXCR4)–ligand interactions on living cancer cells
D Brancaccio, D Diana, S Di Maro, FS Di Leva, S Tomassi, R Fattorusso, ...
Journal of Medicinal Chemistry 61 (7), 2910-2923, 2018
252018
Switchable protecting strategy for solid phase synthesis of DNA and RNA interacting nucleopeptides
ME Mercurio, S Tomassi, M Gaglione, R Russo, A Chambery, S Lama, ...
The Journal of organic chemistry 81 (23), 11612-11625, 2016
242016
Structure–activity relationships and biological characterization of a novel, potent, and serum stable CXC chemokine receptor type 4 (CXCR4) antagonist
S Di Maro, FS Di Leva, AM Trotta, D Brancaccio, L Portella, M Aurilio, ...
Journal of Medicinal Chemistry 60 (23), 9641-9652, 2017
232017
Click‐Chemistry (CuAAC) Trimerization of an αvβ6 Integrin Targeting Ga‐68‐Peptide: Enhanced Contrast for in‐Vivo PET Imaging of Human Lung …
NG Quigley, S Tomassi, FS Di Leva, S Di Maro, F Richter, K Steiger, ...
ChemBioChem 21 (19), 2836-2843, 2020
212020
Simultaneous targeting of RGD-integrins and dual murine double minute proteins in glioblastoma multiforme
F Merlino, S Daniele, V La Pietra, S Di Maro, FS Di Leva, D Brancaccio, ...
Journal of Medicinal Chemistry 61 (11), 4791-4809, 2018
202018
tert‐Butylcarbamate‐Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells
S Valente, D Trisciuoglio, M Tardugno, R Benedetti, D Labella, D Secci, ...
ChemMedChem 8 (5), 800-811, 2013
172013
The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins
BS Ludwig, S Tomassi, S Di Maro, FS Di Leva, A Benge, F Reichart, ...
Biomaterials 271, 120754, 2021
162021
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models
M Menna, F Fiorentino, B Marrocco, A Lucidi, S Tomassi, D Cilli, ...
European Journal of Medicinal Chemistry 237, 114410, 2022
142022
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells
V Ciaramella, CM Della Corte, C Di Mauro, S Tomassi, S Di Maro, ...
Oncotarget 9 (27), 19273, 2018
122018
The system can't perform the operation now. Try again later.
Articles 1–20